Publication | Closed Access

Plasma let-7i, miR-16, and miR-221 levels as candidate biomarkers for the assessment of ankylosing spondylitis in Mexican patients naïve to anti-TNF therapy

ImmunologyPathologyCandidate BiomarkersAxial SpondyloarthritisInflammationRheumatoid DisorderMexican PatientsOsteoarthritisInflammatory MarkerInflammatory Rheumatic DiseaseMir-221 LevelsMolecular DiagnosticsRheumatoid ArthritisRheumatologyAutoimmune DiseaseSpondyloarthritisRheumatic DiseasesSclerodermaMedicine